Aytu Biopharma (AYTU) Gross Margin (2014 - 2026)
Aytu Biopharma (AYTU) posted quarterly Gross Margin of 61.23% for Q1 2026, down 817.0% year-over-year from 8.54% in Q1 2025, and down 3.52% quarter-over-quarter from 63.46% in Q4 2025.
Aytu Biopharma (AYTU) Gross Margin (2014 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Gross Margin for 13 consecutive years, with 61.23% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin fell 817.0% year-over-year to 61.23%; the TTM figure through Mar 2026 stood at 64.78% (down 604.0% YoY), while the FY2025 annual figure was 69.04%, down 621.0% from the prior year.
- Gross Margin declined to 61.23% in Q1 2026 per AYTU's latest filing, from 63.46% in the prior quarter.
- Across five years, Gross Margin topped out at 77.89% in Q4 2023 and bottomed at 52.42% in Q1 2022.
- Historically, Gross Margin has averaged 65.97% across 5 years, with a median of 66.14% in 2025.
- On a YoY basis, Gross Margin climbed as much as 1782 bps in 2024 and fell as far as 1140 bps in 2024.
- Aytu Biopharma's Gross Margin stood at 65.81% in 2022, then grew by 18 bps to 77.89% in 2023, then declined by 15 bps to 66.49% in 2024, then decreased by 5 bps to 63.46% in 2025, then slipped by 4 bps to 61.23% in 2026.
- Business Quant data shows AYTU's Gross Margin at 61.23% in Q1 2026, 63.46% in Q4 2025, and 66.14% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aytu Biopharma | 24.49 Mn | -2.22 Mn | 7.60 Mn | 61.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.23% |
| Dec 31, 2025 | 63.46% |
| Sep 30, 2025 | 66.14% |
| Jun 30, 2025 | 67.75% |
| Mar 31, 2025 | 69.40% |
| Dec 31, 2024 | 66.49% |
| Sep 30, 2024 | 72.31% |
| Jun 30, 2024 | 75.73% |
| Mar 31, 2024 | 73.88% |
| Dec 31, 2023 | 77.89% |
| Sep 30, 2023 | 73.18% |
| Jun 30, 2023 | 60.41% |
| Mar 31, 2023 | 56.06% |
| Dec 31, 2022 | 65.81% |
| Sep 30, 2022 | 65.20% |
| Jun 30, 2022 | 54.07% |
| Mar 31, 2022 | 52.42% |
| Dec 31, 2021 | 53.18% |
| Sep 30, 2021 | 56.88% |
| Jun 30, 2021 | 48.12% |